Gencell Ltd
GNCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10 | $5 | $7 | $6 |
| % Growth | 96.3% | -34.3% | 28.5% | – |
| Cost of Goods Sold | $10 | $10 | $10 | $10 |
| Gross Profit | -$1 | -$5 | -$3 | -$4 |
| % Margin | -9.9% | -106.3% | -34.2% | -75.9% |
| R&D Expenses | $8 | $13 | $8 | $5 |
| G&A Expenses | $2 | $7 | $6 | $7 |
| SG&A Expenses | $3 | $11 | $11 | $12 |
| Sales & Mktg Exp. | $2 | $4 | $5 | $5 |
| Other Operating Expenses | $6 | $0 | $0 | -$0 |
| Operating Expenses | $18 | $24 | $18 | $17 |
| Operating Income | -$19 | -$30 | -$22 | -$20 |
| % Margin | -201% | -608.4% | -303.2% | -354.5% |
| Other Income/Exp. Net | -$0 | $1 | -$14 | -$1 |
| Pre-Tax Income | -$19 | -$28 | -$36 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$19 | -$28 | -$37 | -$21 |
| % Margin | -203.5% | -581.9% | -495.4% | -366.1% |
| EPS | -0.18 | -0.26 | -0.34 | -0.22 |
| % Growth | 30.8% | 23.5% | -54.5% | – |
| EPS Diluted | -0.18 | -0.26 | -0.34 | -0.22 |
| Weighted Avg Shares Out | 109 | 108 | 108 | 96 |
| Weighted Avg Shares Out Dil | 109 | 108 | 108 | 96 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $3 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $2 | $2 | $1 | $1 |
| EBITDA | -$18 | -$27 | -$33 | -$19 |
| % Margin | -184.4% | -544.9% | -452.4% | -335.8% |